European Heart Journal Advance Access originally published online on February 21, 2005
European Heart Journal 2005 26(6):576-583; doi:10.1093/eurheartj/ehi074
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist's panacea or the surgeon's headache?
1Section of Cardiac Surgery, Department of Surgery, Washington Hospital Center, 106 Irving Street, NW, Suite 316, Washington, DC 20010-2975, USA
2Department of Epidemiology and Statistics, MedStar Research Institute, Washington, DC, USA
Received 3 May 2004; revised 28 September 2004; accepted 16 November 2004; online publish-ahead-of-print 21 February 2005.
* Corresponding author. Tel: +1 202 877 0277; fax: +1 202 291 1444. E-mail address: emmanouil_kapetanakis{at}yahoo.com
Aims Thrombotic complications after percutaneous coronary intervention procedures have decreased in past years mainly due to the use of clopidogrel antiplatelet therapy. However, the risk of bleeding due to enhanced and irreversible platelet inhibition in patients who will require surgical coronary revascularization instead has not been adequately addressed in the literature. The purpose of this study was to evaluate the effect of pre-operative clopidrogel exposure in haemorrhage-related re-exploration rates, peri-operative transfusion requirements, morbidity, and mortality in patients undergoing coronary artery bypass grafting (CABG) surgery.
Methods and results A study population of 2359 patients undergoing isolated CABG between January 2000 and June 2002 was reviewed. Of these, 415 (17.6%) received clopidogrel prior to CABG surgery, and 1944 (82.4%) did not. A risk-adjusted logistic regression analysis was used to assess the association between clopidogrel pre-medication (vs. no) and haemostatic re-operation, intraoperative and post-operative blood transfusion rates, and multiple transfusions received. Haemorrhage-related pre-operative risk factors identified from the literature and those found significant in a univariate model were used. Furthermore, a sub-cohort, matched-pair by propensity scores analysis, was also conducted. The clopidogrel group had a higher likelihood of haemostatic re-operation [OR=4.9, (95% CI, 2.63–8.97), P<0.01], an increase in total packed red blood cell transfusions [OR=2.2, (95% CI, 1.70–2.84), P<0.01], multiple unit blood transfusions [OR=1.9, (95% CI, 1.33–2.75), P<0.01] and platelet transfusions [OR=2.6, (95% CI, 1.95–3.56), P<0.01]. Surgical outcomes and operative mortality [OR=1.5, (95% CI, 0.36–6.51), P=0.56] were not significantly different.
Conclusion Pre-operative clopidogrel exposure increases the risk of haemostatic re-operation and the requirements for blood and blood product transfusion during, and after, CABG surgery.
Key Words: Clopidogrel • Coronary artery bypass graft surgery • Re-operation due to bleeding • Transfusion rates • Haemostasis
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. C. Austin Primer on Statistical Interpretation or Methods Report Card on Propensity-Score Matching in the Cardiology Literature From 2004 to 2006: A Systematic Review Circ Cardiovasc Qual Outcomes, September 1, 2008; 1(1): 62 - 67. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. T. Newsome, R. S. Weller, J. C. Gerancher, M. A. Kutcher, and R. L. Royster Coronary Artery Stents: II. Perioperative Considerations and Management Anesth. Analg., August 1, 2008; 107(2): 570 - 590. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Dunning, M. Versteegh, A. Fabbri, A. Pavie, P. Kolh, U. Lockowandt, S. A.M. Nashef, and on behalf of the EACTS Audit and Guidelines Commit Guideline on antiplatelet and anticoagulation management in cardiac surgery. Eur. J. Cardiothorac. Surg., July 1, 2008; 34(1): 73 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. I. Weitz, J. Hirsh, and M. M. Samama New Antithrombotic Drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 234S - 256S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Becker Emerging constructs to maintain safety among patients with acute coronary syndromes requiring surgical coronary revascularization Eur. Heart J. Suppl., May 1, 2008; 10(suppl_D): D12 - D22. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. George and M. C. Oz Myocardial Revascularization after Acute Myocardial Infarction Card. Surg. Adult, January 1, 2008; 3(2008): 669 - 696. [Full Text]
|
|
|
|
 |
|
 J. J. Andreasen, M. Westen, P. A. Pallesen, S. Jensen, A. Gorst-Rasmussen, and S. P. Johnsen Transfusion practice in coronary artery bypass surgery in Denmark: a multicenter audit Interactive CardioVascular and Thoracic Surgery, October 1, 2007; 6(5): 623 - 627. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.-G. Chassot, A. Delabays, and D. R. Spahn Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction Br. J. Anaesth., September 1, 2007; 99(3): 316 - 328. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Shim, Y. S. Choi, Y. J. Oh, S. O. Bang, K. J. Yoo, and Y. L. Kwak Effects of preoperative aspirin and clopidogrel therapy on perioperative blood loss and blood transfusion requirements in patients undergoing off-pump coronary artery bypass graft surgery J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 59 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Kunadian, A. R. Thornley, M. Tanos, and J. Dunning Should clopidogrel be stopped prior to urgent cardiac surgery? Interactive CardioVascular and Thoracic Surgery, October 1, 2006; 5(5): 630 - 636. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Eikelboom and J. Hirsh Bleeding and management of bleeding Eur. Heart J. Suppl., October 1, 2006; 8(suppl_G): G38 - G45. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Spahn, S. J. Howell, A. Delabays, and P.-G. Chassot Coronary stents and perioperative anti-platelet regimen: dilemma of bleeding and stent thrombosis. Br. J. Anaesth., June 1, 2006; 96(6): 675 - 677. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Lecompte and J.-F. Hardy Antiplatelet agents and perioperative bleeding: [Les inhibiteurs plaquettaires et le saignement perioperatoire]. Can J Anesth, June 1, 2006; 53(6_suppl): S103 - S112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Jones The Year in Cardiovascular Surgery J. Am. Coll. Cardiol., May 16, 2006; 47(10): 2094 - 2107. [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Bavry and A. M. Lincoff Is Clopidogrel Cardiovascular Medicine's Double-Edged Sword? Circulation, April 4, 2006; 113(13): 1638 - 1640. [Full Text] [PDF]
|
|
|
|
|
|
R. P. Giugliano and E. Braunwald The Year in Non--ST-Segment Elevation Acute Coronary Syndromes J. Am. Coll. Cardiol., September 6, 2005; 46(5): 906 - 919. [Full Text] [PDF]
|
|